After stroke the Shh pathway is upregulated in multiple cell types and post-stroke treatment with an SHH agonist in a distal middle cerebral artery occlusion model leads to functional improvement in the subacute phase after stroke [100]. The gene discussed is SHH; the disease is Stroke.